查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1825958

2025年3D細胞培養技術全球市場報告

3D Cell Culture Technologies Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，3D細胞培養技術的市場規模迅速擴張，從2024年的33.6億美元成長到2025年的39.6億美元，複合年成長率為17.9%。預測期內的成長歸因於細胞生物學、藥物研發的進步、慢性病盛行率的上升以及政府資金的投入。

預計未來幾年，3D細胞培養技術市場規模將快速成長，到2029年將達到81.6億美元，複合年成長率為19.8%。預測期內的成長可歸因於製藥業的發展、研發的不斷加強以及環境和倫理方面的考量。預測期內的主要趨勢包括個人化醫療、技術進步、生物列印和再生醫學。

細胞培養是生產安全病毒疫苗的關鍵工序。 3D細胞培養是一種先進的體外技術，可使細胞在人工設計的環境中生長。

3D細胞培養技術主要分為基於支架的、無支架的和3D反應器。例如，3D反應器是一種專門用於3D細胞培養的塑膠圓柱形腔室。這些技術應用於癌症研究、幹細胞研究、藥物研發和再生醫學等各個領域。其用戶範圍廣泛，包括研究機構、生技公司、製藥公司、醫院和診斷中心。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療保健領域產生了重大影響，尤其是對基本醫療設備、診斷設備和藥品的供應。醫院和醫療機構正疲於應對進口手術器械、診斷影像系統以及注射器和導管等消耗品不斷上漲的成本，而這些產品中的許多在國內的替代品有限。由於這些不斷上漲的成本給醫療保健預算帶來壓力，一些醫療機構正在推遲設備升級或將增加的費用轉嫁給患者。此外，原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產，導致供應鏈延遲。作為應對措施，該行業正在採用多樣化的籌資策略，盡可能擴大本地生產，並遊說對關鍵醫療產品免關稅。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供 3D 細胞培養技術市場統計數據，例如全球市場規模、各地區市場佔有率、競爭對手的市場佔有率、詳細的 3D 細胞培養技術細分市場、市場趨勢和機遇，以及您在 3D 細胞培養技術行業取得成功所需的數據。這份 3D 細胞培養技術市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年的預測成長率為19.8%，較我們先前對該市場的預測略有下降0.4%。這一下降主要源自於美國與其他國家之間關稅的影響。預計關稅壁壘將透過提高來自瑞士和韓國的反應器和合成細胞外基質的成本，阻礙美國市場的發展，從而減緩個人化醫療和類器官研究的進展。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，其影響也將更加廣泛。

器官移植需求是3D細胞培養技術市場的主要驅動力。 3D細胞培養在創建與組織和器官非常相似的3D結構方面發揮關鍵作用，有助於器官移植的成功。此外，3D細胞結構提供了組織和器官再生的潛力，並可作為藥物毒性篩檢的寶貴工具。例如，2023年1月，美國非營利組織UNOS（器官共享聯合網路）的數據顯示，2022年美國器官移植數量增加了3.7％，共進行了42,887例。 2022年死者器官捐贈者數量達到創紀錄的14,903人，連續第12年成長，比2021年成長了7.5％。這一成長部分歸因於死者器官捐贈的醫學標準擴大，臨床結果良好，增加了非傳統資格類別的捐贈者比例。值得注意的是，2022年循環死亡後捐贈（DCD捐贈者）數量較2021年增加近14%，50歲以上捐贈者數量首次在一年內超過5000人，總合達到5789人。

3D 細胞培養技術市場的預期成長很大程度上歸功於藥物發現日益成長的勢頭，這涉及透過結合計算、實驗、轉化和臨床建模來尋找潛在的新藥化合物。 3D 細胞培養技術在藥物發現領域的重要性日益凸顯，因為它可以提供更準確、更可靠的結果。它能夠進行微尺度 3D 培養，為臨床結果提供很高的預測價值，且無需動物模型。例如，截至 2023 年 1 月，美國食品藥物管理局(FDA) 報告稱， 美國的藥品評估和研究中心 (CDER) 在 2022 年核准了37 種用於各種醫療適應症的新藥和治療生技藥品。這再次肯定了 3D 細胞培養技術在藥物發現進程中的重要作用，並正在推動 3D 細胞培養技術市場的成長。

3D 細胞培養市場的當前趨勢圍繞著採用最尖端科技。多家公司已在這一領域取得了顯著進展：使用體內/體外環境。雖然傳統的 2D 體外模型在細胞生長和相互作用方面有其局限性，但 3D 細胞培養技術為細胞培養提供了更合適的環境。體外環境使研究人員和醫療專業人員能夠在生物體外的受控環境中執行程序。這種方法越來越重要，特別是在患者健康監測方面。值得注意的是，FDA 已批准 BIoTek 的 3D 細胞生長系統作為醫療設備。此外，BIoTek 的聚己內酯 (PCL) 是一種可生物分解的聚酯材料，用於多種 FDA 批准的植入和藥物輸送裝置，也已獲得 FDA 的批准。這反映出在 3D 細胞培養市場採用尖端技術的重要性日益增加。

3D細胞培養技術市場的主要企業正在策略性地推出PODS-PeptiGels等創新產品，以增強其競爭地位。 PODS-PeptiGels是一種結合兩種先進細胞培養技術的新方法：合成胜肽水凝膠（PeptiGels）和多種緩釋性生長因子（PODS）。這種組合為3D細胞培養提供了高度可重複和適應性強的環境。例如，2022年4月，英國生物技術公司Cell Guidance Systems報告稱，它已與Manchester BioGel合作推出了用於3D細胞培養的PODS-PeptiGels。這款即用型套件使研究人員能夠客製化方法以滿足其研究目標。研究人員可以從70多種生長因子中進行選擇，並將它們與各種水凝膠結合，每種水凝膠都具有特異性的機械和仿生特性。 Manchester BioGel也是一家總部位於英國的生物技術公司，專門從事3D合成胜肽水凝膠的設計和製造。這些創新產品的策略性引入表明了我們致力於在 3D 細胞培養技術市場中保持競爭力。

2022年12月，美國研發公司Molecular Devices LLC收購了Cellesce Ltd.，收購金額未揭露。此次收購彰顯了Molecular Devices致力於推動3D生物技術的承諾，旨在徹底改變藥物研發流程並支持創新療法的開發。 Cellesce Ltd.是一家專注於3D細胞培養技術的美國公司。

3D細胞培養技術市場涵蓋3D細胞培養技術的銷售，包括微射流、水凝膠支架、無支架3D細胞培養技術、球狀體、立方體、球形液滴、堆疊板、磁珠和器官晶片。此市場的價值為出廠價，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球3D細胞培養技術：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球3D細胞培養技術市場：成長率分析
  • 全球3D細胞培養技術市場表現：規模與成長，2019-2024年
  • 全球 3D 細胞培養技術市場預測：規模與成長，2024-2029 年，2034 年
  • 全球 3D 細胞培養技術：總目標市場 (TAM)

第6章 市場細分

  • 全球3D細胞培養技術市場類型、表現及預測（2019-2024年、2024-2029年、2034年）
  • 鷹架底座
  • 無支架
  • 3D反應器
  • 全球3D細胞培養技術市場的應用、效能與預測（2019-2024年、2024-2029年、2034年）
  • 癌症研究
  • 幹細胞研究
  • 藥物研發
  • 再生醫學
  • 全球 3D 細胞培養技術市場（依最終用戶、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 實驗室和實驗室
  • 生物技術和製藥公司
  • 醫院和診斷中心
  • 其他
  • 全球 3D 細胞培養技術市場：基於支架的細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 天然支架
  • 合成支架
  • 混合鷹架
  • 全球 3D 細胞培養技術市場：無支架細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 球形底座
  • 基於類器官
  • 全球 3D 細胞培養技術市場：3D反應器細分、類型、性能及預測（2019-2024 年、2024-2029 年、2034 年）
  • 槳鼻罩燒瓶反應器
  • 旋轉壁反應器
  • 基於微載體的反應器
  • 中空纖維反應器

第7章 區域和國家分析

  • 全球3D細胞培養技術市場：依地區、績效及預測，2019-2024年、2024-2029年、2034年
  • 全球3D細胞培養技術市場：依國家/地區、績效及預測（2019-2024年、2024-2029年、2034年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 3D細胞培養技術市場：競爭格局
  • 3D細胞培養技術市場：公司簡介
    • Becton Dickinson and Company
    • Corning Incorporated
    • Eppendorf AG
    • GE醫療集團（通用電氣公司的一個部門）
    • Merck KGaA

第31章：其他領先和創新企業

  • Thermo Fisher Scientific Inc.
  • Lonza Group AG
  • HiMedia Laboratories Pvt. Ltd.
  • Agilent Technologies Inc.
  • PromoCell GmbH
  • CellGenix GmbH
  • Greiner Bio-One International GmbH
  • Irvine Scientific Sales Company Inc.
  • Cell Culture Company LLC
  • SeraCare Life Sciences Inc.
  • American Type Culture Collection（ATCC）
  • Miltenyi BIoTec BV & Co. KG
  • AITbIoTech Pte Ltd
  • Essen BioScience, a Sartorius Company
  • Sigma-Aldrich

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年3D細胞培養技術市場：提供新機會的國家
  • 2029年3D細胞培養技術市場：細分領域帶來新機會
  • 2029年3D細胞培養技術市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r32358u

Cell culture is a critical process in the production of safe viral vaccines. 3D cell culture represents an advanced in vitro technique where cells can thrive within an artificially engineered environment.

The primary categories of 3D cell culture technologies are scaffold-based, scaffold-free, and 3D bioreactors. 3D bioreactors, for instance, are specialized plastic cylinder chambers tailored for cultivating cells in a three-dimensional fashion. These technologies find application in various fields, including cancer research, stem cell research, drug discovery, and regenerative medicine. They are utilized by a wide range of users, including research laboratories, biotechnology and pharmaceutical companies, hospitals, diagnostic centers, and other institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The 3D cell culture technologies market research report is one of a series of new reports from The Business Research Company that provides 3D cell culture technologies market statistics, including 3D cell culture technologies industry global market size, regional shares, competitors with a 3D cell culture technologies market share, detailed 3D cell culture technologies market segments, market trends and opportunities, and any further data you may need to thrive in the 3D cell culture technologies industry. This 3D cell culture technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The 3D cell culture technologies market size has grown rapidly in recent years. It will grow from $3.36 billion in 2024 to $3.96 billion in 2025 at a compound annual growth rate (CAGR) of 17.9%. The growth in the historic period can be attributed to advancements in cell biology, drug development, rising incidence of chronic diseases, government funding.

The 3D cell culture technologies market size is expected to see rapid growth in the next few years. It will grow to $8.16 billion in 2029 at a compound annual growth rate (CAGR) of 19.8%. The growth in the forecast period can be attributed to pharmaceutical industry, increasing research and development, environmental and ethical considerations. Major trends in the forecast period include personalized medicine, technological advancements, bioprinting, regenerative medicine.

The forecast of 19.8% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of bioreactors and synthetic extracellular matrices sourced from Switzerland and South Korea, thereby slowing down progress in personalized medicine and organoid research. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The demand for organ transplantation is a key driver for the 3D Cell Culture Technologies Market. 3D cell culture plays a crucial role in creating three-dimensional structures that closely resemble tissues and organs, making it instrumental for successful organ transplantation. Furthermore, 3D cell structures offer the potential for tissue and organ regeneration and serve as a valuable tool for drug toxicity screening. For instance, in January 2023, data from the United Network for Organ Sharing (UNOS), a US-based non-profit organization, revealed that in 2022, the United States witnessed a 3.7% increase in organ transplants, with 42,887 procedures performed. A record-breaking 14,903 individuals became deceased organ donors in 2022, marking the twelfth consecutive year of growth and a 7.5% increase over 2021. This growth is partly attributed to the broadening of medical criteria for deceased organ donation based on positive clinical outcomes, leading to a higher proportion of donors from non-traditional eligibility categories. Notably, there was a nearly 14% increase in donations after circulatory death (DCD donors) in 2022 compared to 2021, and for the first time, there were more than 5,000 donors aged 50 or older in a single year, with 5,789 in total.

The anticipated growth of the 3D cell culture technologies market is largely attributed to the increasing momentum in drug discovery. Drug discovery involves the exploration of potential new medicinal compounds through a combination of computational, experimental, translational, and clinical models. Notably, 3D cell culture technologies are gaining significance in the realm of drug discovery due to their ability to provide more precise and dependable results. They enable microscale 3D cultures, offer higher predictive value for clinical outcomes, and eliminate the need for animal models. For example, as of January 2023, the Food and Drug Administration (FDA), a US federal agency under the Department of Health and Human Services, reported the approval of 37 new drugs and therapeutic biological products by the FDA's Centre for Drug Evaluation and Research (CDER) in the United States for various medical indications in 2022. This reaffirms the crucial role of 3D cell culture technologies in advancing drug discovery, making it a driving force behind the growth of the 3D cell culture technologies market.

The current trend in the 3D Cell Culture market revolves around the adoption of cutting-edge technology. Several companies have embraced a notable advancement in this sector, namely the utilization of in vivo/in vitro environments. Traditional cell expansion and interactions in 2D in vitro models have limitations, but when compared to the 3D cell culture technique, the latter offers a more conducive environment for cell culture. The in vitro environment empowers researchers and medical professionals to carry out procedures within a controlled setting outside the living organism. This approach is gaining significant importance, particularly in the context of patient health monitoring. Notably, the FDA has granted approval for Biotek's 3D cell expansion system to be used as a medical device. Additionally, Biotek's Polycaprolactone (PCL), a biodegradable polyester material utilized in numerous FDA-approved implants and drug delivery devices, has also received FDA approval. This reflects the growing significance of advanced technology adoption in the 3D Cell Culture market.

Prominent players in the 3D Cell Culture Technologies market are strategically introducing innovative products, such as PODS-PeptiGels, to enhance their competitive position. PODS-PeptiGels represents a novel approach that combines two advanced cell culture technologies such as synthetic peptide hydrogels (PeptiGels) and a diverse array of sustained-release growth factors (PODS). This combination results in a reproducible and highly adaptable environment for 3D cell culture. For example, in April 2022, as reported by Cell Guidance Systems, a UK-based biotechnology company, a collaboration with Manchester BIOGEL led to the launch of PODS-PeptiGels for 3D cell culture. This ready-to-use kit empowers researchers to customize their approach to align with the objectives of their research. They can choose from a selection of over 70 growth factors and combine them with a wide variety of hydrogels, each offering specific mechanical and biomimetic properties. Manchester Biogel, another UK-based biotechnology company, specializes in the design and manufacturing of 3D synthetic peptide hydrogels. This strategic introduction of innovative products demonstrates a commitment to staying competitive in the 3D Cell Culture Technologies market.

In December 2022, Molecular Devices LLC, a US-based research and development company, acquired Cellesce Ltd. for an undisclosed amount. This acquisition highlights Molecular Devices' dedication to advancing 3D biology technologies, aiming to revolutionize the drug discovery process and support the development of innovative therapeutics. Cellesce Ltd. is a US-based company specializing in 3D cell culture technologies.

Major companies operating in the 3D cell culture technologies market include Becton Dickinson and Company, Corning Incorporated, Eppendorf AG, GE Healthcare a division of General Electric Company, Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group AG, HiMedia Laboratories Pvt. Ltd., Agilent Technologies Inc., PromoCell GmbH, CellGenix GmbH, Greiner Bio-One International GmbH, Irvine Scientific Sales Company Inc., Cell Culture Company LLC, SeraCare Life Sciences Inc., American Type Culture Collection (ATCC), Miltenyi Biotec B.V. & Co. KG, AITbiotech Pte Ltd, Essen BioScience a Sartorius Company, Sigma-Aldrich, Bel-Art Products Inc., MilliporeSigma, Sumitomo Bakelite, EMD Millipore, Affymetrix Inc., VWR International llc., WHEATON IndustriesInc, Sartorius AG, CN Bio Innovations, Nortis Inc., Kiyatec, Nanofiber Solutions, Copner Biotech, Known Medicine, Synthecon Inc., 3D Biotek LLC, 3D Cell Culture Innovations LLC., 3D Matrix Inc., Allevi Inc., BioSpherix Ltd., Emulate Inc., MicroTissues Inc.

North America was the largest region in the 3D cell culture technologies market in 2024. Western Europe was the second largest region in the 3D cell culture technologies market. The regions covered in the 3d cell culture technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the 3D cell culture technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The 3D cell culture technologies market consists of sales of 3D cell culture technologies such as microfluidics, hydrogels scaffolds, scaffold-free 3D cell culture techniques, spheroids, cube, spherical droplet, stacked plate, magnetic bead, organ-on-chips and other technologies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

3D Cell Culture Technologies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on 3d cell culture technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for 3d cell culture technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The 3d cell culture technologies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Scaffold-based; Scaffold-free; 3D Bioreactors
  • 2) By Application: Cancer Research; Stem Cell Research; Drug Discovery; Regenerative Medicine
  • 3) By End Users: Research Laboratories and Institutes; Biotechnology and Pharmaceutical Companies; Hospitals and Diagnostic Centers; Other End Users
  • Subsegments:
  • 1) By Scaffold-Based: Natural Scaffolds; Synthetic Scaffolds; Hybrid Scaffolds
  • 2) By Scaffold-Free: Spheroid-Based; Organoid-Based
  • 3) By 3D Bioreactors: Spinner Flask Bioreactors; Rotating Wall Bioreactors; Microcarrier-Based Bioreactors; Hollow Fiber Bioreactors
  • Companies Mentioned: Becton Dickinson and Company; Corning Incorporated; Eppendorf AG; GE Healthcare a division of General Electric Company; Merck KGaA; Thermo Fisher Scientific Inc.; Lonza Group AG; HiMedia Laboratories Pvt. Ltd.; Agilent Technologies Inc.; PromoCell GmbH; CellGenix GmbH; Greiner Bio-One International GmbH; Irvine Scientific Sales Company Inc.; Cell Culture Company LLC; SeraCare Life Sciences Inc.; American Type Culture Collection (ATCC); Miltenyi Biotec B.V. & Co. KG; AITbiotech Pte Ltd; Essen BioScience a Sartorius Company; Sigma-Aldrich; Bel-Art Products Inc.; MilliporeSigma; Sumitomo Bakelite; EMD Millipore; Affymetrix Inc.; VWR International llc.; WHEATON IndustriesInc; Sartorius AG; CN Bio Innovations; Nortis Inc.; Kiyatec; Nanofiber Solutions; Copner Biotech; Known Medicine; Synthecon Inc.; 3D Biotek LLC; 3D Cell Culture Innovations LLC.; 3D Matrix Inc.; Allevi Inc.; BioSpherix Ltd.; Emulate Inc.; MicroTissues Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. 3D Cell Culture Technologies Market Characteristics

3. 3D Cell Culture Technologies Market Trends And Strategies

4. 3D Cell Culture Technologies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global 3D Cell Culture Technologies Growth Analysis And Strategic Analysis Framework

  • 5.1. Global 3D Cell Culture Technologies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global 3D Cell Culture Technologies Market Growth Rate Analysis
  • 5.4. Global 3D Cell Culture Technologies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global 3D Cell Culture Technologies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global 3D Cell Culture Technologies Total Addressable Market (TAM)

6. 3D Cell Culture Technologies Market Segmentation

  • 6.1. Global 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Scaffold-based
  • Scaffold-free
  • 3D Bioreactors
  • 6.2. Global 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Research
  • Stem Cell Research
  • Drug Discovery
  • Regenerative Medicine
  • 6.3. Global 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research Laboratories and Institutes
  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Diagnostic Centers
  • Other End Users
  • 6.4. Global 3D Cell Culture Technologies Market, Sub-Segmentation Of Scaffold-Based, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Natural Scaffolds
  • Synthetic Scaffolds
  • Hybrid Scaffolds
  • 6.5. Global 3D Cell Culture Technologies Market, Sub-Segmentation Of Scaffold-Free, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spheroid-Based
  • Organoid-Based
  • 6.6. Global 3D Cell Culture Technologies Market, Sub-Segmentation Of 3D Bioreactors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spinner Flask Bioreactors
  • Rotating Wall Bioreactors
  • Microcarrier-Based Bioreactors
  • Hollow Fiber Bioreactors

7. 3D Cell Culture Technologies Market Regional And Country Analysis

  • 7.1. Global 3D Cell Culture Technologies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global 3D Cell Culture Technologies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific 3D Cell Culture Technologies Market

  • 8.1. Asia-Pacific 3D Cell Culture Technologies Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China 3D Cell Culture Technologies Market

  • 9.1. China 3D Cell Culture Technologies Market Overview
  • 9.2. China 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India 3D Cell Culture Technologies Market

  • 10.1. India 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan 3D Cell Culture Technologies Market

  • 11.1. Japan 3D Cell Culture Technologies Market Overview
  • 11.2. Japan 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia 3D Cell Culture Technologies Market

  • 12.1. Australia 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia 3D Cell Culture Technologies Market

  • 13.1. Indonesia 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea 3D Cell Culture Technologies Market

  • 14.1. South Korea 3D Cell Culture Technologies Market Overview
  • 14.2. South Korea 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe 3D Cell Culture Technologies Market

  • 15.1. Western Europe 3D Cell Culture Technologies Market Overview
  • 15.2. Western Europe 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK 3D Cell Culture Technologies Market

  • 16.1. UK 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany 3D Cell Culture Technologies Market

  • 17.1. Germany 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France 3D Cell Culture Technologies Market

  • 18.1. France 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy 3D Cell Culture Technologies Market

  • 19.1. Italy 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain 3D Cell Culture Technologies Market

  • 20.1. Spain 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe 3D Cell Culture Technologies Market

  • 21.1. Eastern Europe 3D Cell Culture Technologies Market Overview
  • 21.2. Eastern Europe 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia 3D Cell Culture Technologies Market

  • 22.1. Russia 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America 3D Cell Culture Technologies Market

  • 23.1. North America 3D Cell Culture Technologies Market Overview
  • 23.2. North America 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA 3D Cell Culture Technologies Market

  • 24.1. USA 3D Cell Culture Technologies Market Overview
  • 24.2. USA 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada 3D Cell Culture Technologies Market

  • 25.1. Canada 3D Cell Culture Technologies Market Overview
  • 25.2. Canada 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America 3D Cell Culture Technologies Market

  • 26.1. South America 3D Cell Culture Technologies Market Overview
  • 26.2. South America 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil 3D Cell Culture Technologies Market

  • 27.1. Brazil 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East 3D Cell Culture Technologies Market

  • 28.1. Middle East 3D Cell Culture Technologies Market Overview
  • 28.2. Middle East 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa 3D Cell Culture Technologies Market

  • 29.1. Africa 3D Cell Culture Technologies Market Overview
  • 29.2. Africa 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. 3D Cell Culture Technologies Market Competitive Landscape And Company Profiles

  • 30.1. 3D Cell Culture Technologies Market Competitive Landscape
  • 30.2. 3D Cell Culture Technologies Market Company Profiles
    • 30.2.1. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Eppendorf AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. GE Healthcare, a division of General Electric Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. 3D Cell Culture Technologies Market Other Major And Innovative Companies

  • 31.1. Thermo Fisher Scientific Inc.
  • 31.2. Lonza Group AG
  • 31.3. HiMedia Laboratories Pvt. Ltd.
  • 31.4. Agilent Technologies Inc.
  • 31.5. PromoCell GmbH
  • 31.6. CellGenix GmbH
  • 31.7. Greiner Bio-One International GmbH
  • 31.8. Irvine Scientific Sales Company Inc.
  • 31.9. Cell Culture Company LLC
  • 31.10. SeraCare Life Sciences Inc.
  • 31.11. American Type Culture Collection (ATCC)
  • 31.12. Miltenyi Biotec B.V. & Co. KG
  • 31.13. AITbiotech Pte Ltd
  • 31.14. Essen BioScience, a Sartorius Company
  • 31.15. Sigma-Aldrich

32. Global 3D Cell Culture Technologies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The 3D Cell Culture Technologies Market

34. Recent Developments In The 3D Cell Culture Technologies Market

35. 3D Cell Culture Technologies Market High Potential Countries, Segments and Strategies

  • 35.1 3D Cell Culture Technologies Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 3D Cell Culture Technologies Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 3D Cell Culture Technologies Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer